241 related articles for article (PubMed ID: 2193101)
1. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
Kovach NL; Yee E; Munford RS; Raetz CR; Harlan JM
J Exp Med; 1990 Jul; 172(1):77-84. PubMed ID: 2193101
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
Wang MH; Flad HD; Feist W; Musehold J; Kusumoto S; Brade H; Gerdes J; Rietschel HT; Ulmer AJ
Lymphokine Cytokine Res; 1992 Feb; 11(1):23-31. PubMed ID: 1576244
[TBL] [Abstract][Full Text] [Related]
3. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
Feist W; Ulmer AJ; Wang MH; Musehold J; Schlüter C; Gerdes J; Herzbeck H; Brade H; Kusumoto S; Diamantstein T
FEMS Microbiol Immunol; 1992 Jan; 4(2):73-89. PubMed ID: 1547025
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A and monophosphoryl lipid A on nitric oxide, TNF-alpha, and IL-6 induction from RAW 264.7 macrophages.
Aybay C; Imir T
FEMS Immunol Med Microbiol; 1998 Nov; 22(3):263-73. PubMed ID: 9848688
[TBL] [Abstract][Full Text] [Related]
5. The antagonist activity of lipid IVa on the stimulation by lipid A of TNF-alpha production from canine blood mononuclear cells.
Takasawa K; Kano R; Maruyama H; Hasegawa A; Kamata H
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):167-9. PubMed ID: 21782253
[TBL] [Abstract][Full Text] [Related]
6. Induction of endothelial tissue factor by endotoxin and its precursors.
Moldow CF; Bach RR; Staskus K; Rick PD
Thromb Haemost; 1993 Oct; 70(4):702-6. PubMed ID: 8116000
[TBL] [Abstract][Full Text] [Related]
7. Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.
Perera PY; Manthey CL; Stütz PL; Hildebrandt J; Vogel SN
Infect Immun; 1993 May; 61(5):2015-23. PubMed ID: 7683001
[TBL] [Abstract][Full Text] [Related]
8. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of lipopolysaccharide-, lipid IVa-, and lipid X-induced tumor necrosis factor production in murine macrophage-like cell lines.
Birkland TP; Cornwell RD; Golenbock DT; Proctor RA
Adv Exp Med Biol; 1990; 256():399-402. PubMed ID: 2327296
[No Abstract] [Full Text] [Related]
10. Chemically detoxified lipid A precursor derivatives antagonize the TNF-alpha-inducing action of LPS in both murine macrophages and a human macrophage cell line.
Tanamoto K
J Immunol; 1995 Dec; 155(11):5391-6. PubMed ID: 7594555
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures.
Flad HD; Loppnow H; Feist W; Wang MH; Brade H; Kusumoto S; Rietschel ET; Ulmer AJ
Lymphokine Res; 1989; 8(3):235-8. PubMed ID: 2789317
[TBL] [Abstract][Full Text] [Related]
12. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
Matsuura M; Kiso M; Hasegawa A; Nakano M
Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures.
Feist W; Ulmer AJ; Musehold J; Brade H; Kusumoto S; Flad HD
Immunobiology; 1989 Oct; 179(4-5):293-307. PubMed ID: 2613271
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
Lynn WA; Raetz CR; Qureshi N; Golenbock DT
J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
[TBL] [Abstract][Full Text] [Related]
15. Agonists and antagonists for lipopolysaccharide-induced cytokines.
Flad HD; Loppnow H; Rietschel ET; Ulmer AJ
Immunobiology; 1993 Apr; 187(3-5):303-16. PubMed ID: 8330901
[TBL] [Abstract][Full Text] [Related]
16. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.
Kirikae T; Schade FU; Zähringer U; Kirikae F; Brade H; Kusumoto S; Kusama T; Rietschel ET
FEMS Immunol Med Microbiol; 1994 Jan; 8(1):13-26. PubMed ID: 8156049
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
[TBL] [Abstract][Full Text] [Related]
18. Specific features of human monocytes activation by monophosphoryl lipid A.
Chentouh R; Fitting C; Cavaillon JM
Sci Rep; 2018 May; 8(1):7096. PubMed ID: 29728623
[TBL] [Abstract][Full Text] [Related]
19. Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a, is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine macrophages.
Joto N; Akimoto T; Someya K; Tohgo A
Cell Immunol; 1995 Jan; 160(1):1-7. PubMed ID: 7531115
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.
Zuckerman SH; Qureshi N
Infect Immun; 1992 Jul; 60(7):2581-7. PubMed ID: 1612727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]